...
首页> 外文期刊>Chemical and Pharmaceutical Bulletin >Dissolution-Enhancing Mechanism of Alkalizers in Poloxamer-Based Solid Dispersions and Physical Mixtures Containing Poorly Water-Soluble Valsartan
【24h】

Dissolution-Enhancing Mechanism of Alkalizers in Poloxamer-Based Solid Dispersions and Physical Mixtures Containing Poorly Water-Soluble Valsartan

机译:泊洛沙姆基固体分散体和水溶性差的缬沙坦的物理混合物中碱化剂的溶解增强机理

获取原文

摘要

The purpose of this study was to investigate the effects of alkalizers in dissolution rate and crystal structure of valsartan (VAL) in Poloxamer 407 (POX)-based solid dispersions (SD). VAL, a poorly-water soluble drug was selected as a model drug because of its low solubility at low pH. The POX-based SDs containing alkalizers (Na2CO3, MgO, meglumine and arginine) were prepared by melting method. The dissolution tests were performed using the United States Pharmacopeia (USP) paddle II method in enzyme-free simulated gastric fluid (pH 1.2) for 2 h. Microenvironmental pH (pHM) was examined potentiometrically by using a surface pH electrode. Dissolution rate of SD incorporating Na2CO3 was drastically increased. The differential scanning calorimetry (DSC) and powder X-ray diffraction (PXRD) data indicated that crystalline structure of VAL in SD was transformed to amorphous form by the addition of alkalizers but could not explain the differences in the dissolution rates. The molecular interaction between VAL and Na2CO3 was observed in the Fourier transform infrared spectroscopy (FT-IR) spectra by the shift of C=O band from 1732 to 1719 cm?1 and the disappearance of carbonyl group at 1598 cm?1. Furthermore, Na2CO3 efficiently modulated pHM by providing a favorable microenvironment for drug dissolution. A combination of SD method and use of alkalizer is a promising approach to modulate release rate of poorly water-soluble and ionizable drug with an aid of changes of drug crystallinity, molecular interaction and pHM.
机译:这项研究的目的是研究碱剂对基于泊洛沙姆407(POX)的固体分散体(SD)中缬沙坦(VAL)的溶解速率和晶体结构的影响。选择VAL(水溶性差的药物)作为模型药物,因为它在低pH下的溶解度低。通过熔融法制备了含有碱化剂(Na 2 CO 3 ,MgO,葡甲胺和精氨酸)的POX基SD。使用美国药典(USP)桨II方法在无酶模拟胃液(pH 1.2)中进行溶出度测试2 h。使用表面pH电极通过电位法检查微环境pH(pH M )。掺入Na 2 CO 3 的SD的溶出速率大大提高。差示扫描量热法(DSC)和粉末X射线衍射(PXRD)数据表明,通过添加碱化剂,可将SD中VAL的晶体结构转变为无定形形式,但不能解释溶解速率的差异。在傅立叶变换红外光谱(FT-IR)光谱中观察到VAL与Na 2 CO 3 之间的分子相互作用,这是因为C = O带从1732移至1719 cm ?1 和1598 cm ?1 羰基的消失。此外,Na 2 CO 3 通过为药物溶解提供有利的微环境而有效地调节pH M 。 SD法和碱化剂的结合使用是通过改变药物结晶度,分子相互作用和pH M 来调节水溶性差和可电离的药物释放速率的一种有前途的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号